NCT01336244View on ClinicalTrials.gov

GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

September 30, 2011

Conditions
Healthy
Interventions
DRUG

GLPG0778

capsules containing 50 or 100 mg of GLPG0778

DRUG

placebo

multiple dose, aqueous formulation, 13 days days, matching ascending dose schedule

Trial Locations (1)

Unknown

SGS Stuivenberg, Antwerp

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY

NCT01336244 - GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study | Biotech Hunter | Biotech Hunter